Main findings
For the first time, we have demonstrated that reduced maternal gestational pulmonary function, assessed by moderate-to-severe reductions in baseline FEV1% predicted is a significant predictor of fetal death. There was no significant association between low maternal FEV1% predicted and adverse maternal outcomes including ACS, acute painful episodes and maternal deaths.